Login / Signup

The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse cystectomy.

Enes Malik AkdaşMustafa Melih ÇulhaEngin TelliEfe BosnalıSerdar BaykalEnes Abdullah BaynalKerem TekeÖnder Kara
Published in: International urology and nephrology (2024)
Intravesical CHT-MMC can be considered as an alternative treatment in selected well-informed patients with non-muscle-invasive papillary urothelial carcinoma who are unresponsive to BCG or intolerant to BCG. Prospectively designed studies with larger number of patients are needed.
Keyphrases
  • end stage renal disease
  • skeletal muscle
  • newly diagnosed
  • ejection fraction
  • urinary tract
  • peritoneal dialysis
  • neoadjuvant chemotherapy
  • lymph node
  • robot assisted
  • replacement therapy